APOE and Alzheimer disease: Masaya et al. identified LRP1 as the potential molecular mechanism by which APOE ε4 in patients with AD intensifies the deposition of Aβ protein in the brain, which was seen both in a mouse model of AD and in autopsies of patients with AD (Tachibana et al., 2019).